LEUNG GABRIEL 4
4 · NovoCure Ltd · Filed Jul 8, 2021
Insider Transaction Report
Form 4
NovoCure LtdNVCR
LEUNG GABRIEL
Director
Transactions
- Exercise/Conversion
Ordinary Shares
2021-07-06$31.45/sh+1,000$31,450→ 73,859 total - Exercise/Conversion
Options to Buy Ordinary Shares
2021-07-06−1,000→ 3,345 totalExercise: $31.45Exp: 2028-05-30→ Ordinary Shares (1,000 underlying) - Sale
Ordinary Shares
2021-07-06$183.54/sh−1,000$183,540→ 72,859 total
Footnotes (2)
- [F1]Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Leung.
- [F2]Fully vested as of the date hereof.